secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0001628280-24-015295
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beauty Health discloses SEC subpoena; finalizes CEO Marla Beck employment terms
-------------------------------------------------------------------------------

- SEC's Enforcement Division issued subpoena in formal investigation; company cooperating, cannot predict scope or outcome.
- Marla Beck named President and CEO effective April 8; receives $1M base salary, $500k special bonus, $6M equity award.
- Annual bonus targeted at 100% of base; equity includes RSUs and PSUs with performance vesting tied to stock price milestones.
- Executive severance plan amended: removes tiers for non-exec officers hired after March 2024, adds tenure-based cash severance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024015295/0001628280-24-015295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024015295/skin-20240405.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-015295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer